HT
ORMP icon

HAP Trading’s Oramed Pharmaceuticals ORMP Stock Holding History

HAP Trading’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,900
Closed -$4K – 2250
2022
Q1 		$4K Buy
+10,900
New +$112K ﹤0.01% 1985
2021
Q4 		– Sell
-51,600
Closed -$729K – 2775
2021
Q3 		$729K Sell
51,600
-74,900
-59% -$1.28M 0.02% 557
2021
Q2 		$716K Buy
126,500
+67,800
+116% +$775K 0.02% 544
2021
Q1 		$157K Buy
58,700
+45,900
+359% +$377K 0.01% 824
2020
Q4 		$5K Buy
+12,800
New +$41.7K ﹤0.01% 2028

Other funds holding ORMP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return